Patents by Inventor Thomas Chris Karagiannis

Thomas Chris Karagiannis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8097238
    Abstract: The present invention relates to cell targeting conjugates and in particular, but not exclusively, to methods of their use in selectively eliminating and in selectively imaging target cells. The invention also relates to processes for production of the conjugates and to intermediate compounds that may be used in production of a specific class of cell targeting conjugates. In one embodiment there is provided a cell targeting conjugate comprising the following components that are covalently conjugated via a linker that is degradable within the target cells: i) a DNA minor groove binding ligand incorporating an effective Auger electron-emitting and/or gamma-emitting and/or positron-emitting atom or photoactive moiety; ii) a target cell specific protein or peptide that is capable of internalization by target cells.
    Type: Grant
    Filed: February 25, 2005
    Date of Patent: January 17, 2012
    Assignee: Peter MacCallum Cancer Institute
    Inventors: Roger Francis Martin, Jonathan Michael White, Pavel Nikolaevich Lobachevsky, Thomas Chris Karagiannis